POLR2A and ependymoma: The possible causative role of somatic POLR2A variants in ependymoma is instead unknown, despite the great advances made in the study of pathogenesis and biological profile of ependymomas, due to the evolution of gene array technology and the recent discovery of novel tumor subgroups based on DNA methylation profiling data (Malbari & Lindsay, 2020).